The cure for cancer may be a ways off, but a young biologist in Madrid identified a plant with quite a bit of promise at slowing the disease. Yes, it's the very same plant that the U.S. Drug Enforcement Agency considers at the top of its schedule of controlled substances: Marijuana. Cristina Sanchez found that aggressive brain cancer cells died every time they were exposed to tetrahydrocannabinol (THC) -- the main psychoactive ingredient in marijuana -- and other "cannabinoids."
Believe it or not ... This happened back in 1998. And ever since, mounting evidence all over the globe has concurred that marijuana shows major promise for slowing cancer growth -- even going so far as to directly attack tumors -- as well as manage many cancer symptoms (nausea, pain, loss of appetite, fatigue).
Research in 2007 even found that cannabidiol (CBD), a nonpsychoactive part of the plant, is a potent inhibitor of breast cancer cell proliferation, metastasis, and tumor growth. The researcher says that cannabidiol may even offer "hope of a non-toxic therapy that could treat aggressive forms of cancer without any of the painful side effects of chemotherapy."
All of that said, it's no wonder that experts are saying cannabinoids "represent a new class of anticancer drugs." But, then, WHY oh WHY then is the DEA still going after medical marijuana dispensaries and patients? Is it because Big Pharma can't synthesize, control, and patent it, and their greed is outweighing the development of natural, side-effect-free cancer treatment? Sadly, if that is the case, I wouldn't be surprised.
But thanks to this eye-opening research, I really do believe people are starting to realize that there are completely legitimate uses for medical marijuana. And given the science, even the government may soon be unable to deny it anymore.
Do you believe marijuana fights cancer and helps manage side effects?
Image via Paige Filler/Flickr